Clarity Medical Group Holding Limited (HKG:1406)
Hong Kong · Delayed Price · Currency is HKD 0.3550
+0.0200 (5.97%)
Apr 14, 2025, 9:50 AM HKT
HKG:1406 Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Revenue Revenue Growth | 176.52 | 190.93 | 213.85 | 225.24 | 222.38 | 218.38 |
Revenue Growth | -7.55% | -10.71% | -5.06% | 1.28% | 1.83% | 5.70% |
Gross Profit Gross Profit Growth | 81.16 | 89.64 | 120.76 | 142.21 | 146.86 | 133.56 |
Operating Income Operating Income Growth | -42.58 | -56.23 | -7.72 | 35.49 | 46.33 | 39.09 |
Net Income Net Income Growth | -74.34 | -75.79 | -3.19 | 13.49 | 35.77 | 26.39 |
Earnings Per Share EPS Growth | -0.14 | -0.14 | -0.01 | 0.03 | 0.10 | 0.09 |
EPS Growth | - | - | - | -63.61% | 0.96% | -15.22% |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Ophthalmic Service Income Ophthalmic Service Income Growth | 165.54 | 179.07 | 206.52 | 217.89 | 215.52 | 212.15 |
Sales of Prescriptions Sales of Prescriptions Growth | 6.95 | 7.69 | 7.33 | 7.35 | 6.86 | 6.22 |
Sales of Vision Products Sales of Vision Products Growth | 4.04 | 4.17 | - | - | - | - |
Total Total Growth | 176.52 | 190.93 | 213.85 | 225.24 | 222.38 | 218.38 |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash & Investments Cash & Investments Growth | 122.39 | 141.43 | 207.5 | 241.27 | 64.86 | 65.65 |
Total Debt Total Debt Growth | 18.67 | 25.41 | 47.26 | 20.18 | 11.96 | 34.19 |
Net Cash (Debt) Net Cash Growth | 103.72 | 116.02 | 160.24 | 221.1 | 52.9 | 31.46 |
Net Cash Growth | -10.60% | -27.59% | -27.53% | 317.92% | 68.14% | 101.58% |
Net Cash Per Share Net Cash Per Share Growth | 0.20 | 0.22 | 0.31 | 0.57 | 0.14 | 0.11 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -6.06 | -15.58 | 16.22 | 27.55 | 71.35 | 41.08 |
Capital Expenditures CapEx Growth | -10.11 | -32.81 | -30.2 | -0.21 | -9.18 | -5.62 |
Free Cash Flow Free Cash Flow Growth | -16.17 | -48.39 | -13.98 | 27.35 | 62.17 | 35.46 |
Free Cash Flow Growth | - | - | - | -56.01% | 75.32% | -34.40% |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Gross Margin | 45.98% | 46.95% | 56.47% | 63.14% | 66.04% | 61.16% |
Operating Margin | -24.12% | -29.45% | -3.61% | 15.75% | 20.83% | 17.90% |
Pretax Margin | -43.21% | -42.89% | -1.36% | 8.46% | 19.70% | 15.19% |
Profit Margin | -42.12% | -39.70% | -1.49% | 5.99% | 16.09% | 12.08% |
FCF Margin | -9.16% | -25.35% | -6.54% | 12.14% | 27.96% | 16.24% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
PE Ratio | - | - | - | 47.23 | - | - |
P/FCF Ratio | - | - | - | 23.30 | - | - |
PS Ratio | 1.06 | 1.88 | 2.32 | 2.83 | - | - |